DR12.3 | Erythroderma Stabilization Before Referral — Summary & Reflection

KEY TAKEAWAYS

Erythroderma (exfoliative dermatitis) is a dermatological emergency defined as generalised inflammatory skin disease involving more than 90% of the body surface area. Its major causes are psoriasis and eczema (commonest), drug reactions and cutaneous T-cell lymphoma (Sézary syndrome), with about a quarter idiopathic. The danger lies in systemic complications: hypothermia, high-output cardiac failure from cutaneous vasodilation, fluid, electrolyte and protein loss with hypoalbuminaemia, and secondary infection progressing to sepsis — the leading cause of death. Primary-care management (DR12.3) is to stabilise before referral: stop the culprit drug if a drug reaction is suspected, restore warmth, give intravenous fluids and correct electrolytes, apply emollients, treat secondary infection, relieve itch and monitor for cardiac failure — while never starting specialist disease-specific therapy. Every patient is referred; the measure of good care is whether the stabilisation bundle was completed before transfer.

REFLECT

Imagine you are the only doctor at a rural health centre when an erythrodermic patient arrives, two hours by ambulance from the nearest dermatology unit. Reflect on the order in which you would act in the first thirty minutes, and why warmth, fluids and infection control come before any attempt to diagnose the cause. Consider how you would explain to the anxious family — who think it is 'only a skin problem' — why their relative is critically ill and must be transferred urgently. How will remembering that 'the patient can die before the diagnosis is made' change the way you triage a red, scaling patient in future?